Abu-Zaid Ahmed, Baradwan Saeed, Alyafi Mohammad, Al Baalharith Maha, Alsehaimi Saud Owaimer, Alsabban Mohannad, Alsharif Saud Abdullah, Alqarni Saad M S, Albelwi Hedaya, Jamjoom Mohammed Ziad, Saleh Saleh A K, Adly Heba M, Alomar Osama, Salem Hany
Department of Biochemistry and Molecular Medicine, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Department of Obstetrics and Gynecology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
Eur J Obstet Gynecol Reprod Biol. 2024 Aug;299:283-288. doi: 10.1016/j.ejogrb.2024.06.031. Epub 2024 Jun 23.
This study aimed to systematically examine the relationship between polycystic ovary syndrome and ovarian, endometrial, and cervical cancers using the National Inpatient Sample (NIS) database.
We utilized the International Classification of Diseases (ICD-10) system to identify relevant codes from the NIS database (2016-2019). Univariate and multivariable regression analyses (adjusted age, race, hospital region, hospital teaching status, income Zip score, smoking, alcohol use, and hormonal replacement therapy) were conducted to evaluate association between PCOS and gynecologic cancers. Results were summarized as odds ratio (OR) with 95% confidence intervals (CI).
Overall, 15,024,965 patients were analyzed, of whom 56,183 and 14,968,782 patients were diagnosed with and without PCOS, respectively. Among the patients diagnosed with gynecologic cancers (n = 91,599), there were 286 with PCOS and 91,313 without PCOS. Univariate analysis revealed that PCOS was significantly associated with higher risk of endometrial cancer (OR = 1.39, 95 % CI [1.18-1.63], p < 0.0001), but lower risk of ovarian cancer (OR = 0.55, 95 % CI [0.45-0.67], p < 0.0001) and cervical cancer (OR = 0.68, 95 % CI [0.51-0.91], p = 0.009). In contrast, after Bonferroni correction, multivariable analysis depicted that PCOS remained significantly associated with higher risk of endometrial cancer (OR = 3.90, 95 % CI [4.32-4.59], p < 0.0001). There was no significant correlation between PCOS and risk of ovarian cancer (OR = 1.09, 95 % CI [0.89-1.34], p = 0.409) and cervical cancer (OR = 0.83, 95 % CI [0.62-1.11], p = 0.218).
This first-ever NIS analysis showed that patients with PCOS exhibited unique gynecologic cancer risk profiles, with higher risk for endometrial cancer, and no significant risk for ovarian or cervical cancers.
本研究旨在利用国家住院样本(NIS)数据库系统地研究多囊卵巢综合征与卵巢癌、子宫内膜癌和宫颈癌之间的关系。
我们使用国际疾病分类(ICD - 10)系统从NIS数据库(2016 - 2019年)中识别相关编码。进行单因素和多因素回归分析(调整年龄、种族、医院地区、医院教学状况、收入邮政编码得分、吸烟、饮酒和激素替代疗法)以评估多囊卵巢综合征与妇科癌症之间的关联。结果以比值比(OR)和95%置信区间(CI)总结。
总体而言,共分析了15,024,965例患者,其中56,183例和14,968,782例患者分别被诊断患有和未患有多囊卵巢综合征。在被诊断患有妇科癌症的患者(n = 91,599)中,有286例患有多囊卵巢综合征,91,313例未患有多囊卵巢综合征。单因素分析显示,多囊卵巢综合征与子宫内膜癌风险较高显著相关(OR = 1.39,95% CI [1.18 - 1.63],p < 0.0001),但与卵巢癌风险较低(OR = 0.55,95% CI [0.45 - 0.67],p < 0.0001)和宫颈癌风险较低(OR = 0.68,95% CI [0.51 - 0.91],p = 0.